secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2023-04-12T23:59:59+00:00
Accession:  0001140361-23-017913
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA Skin pre-announces Q1 2023 revenue $7.3-$7.8M, best Q1 since 2016
------------------------------------------------------------------------

- Preliminary Q1 2023 revenue $7.3-$7.8 million, strongest first quarter since 2016.
- Placed 44 TheraClear X devices in Q1; over 3,000 treatments sold since Jan 2023 launch.
- Converted 86 Pharos accounts to XTRAC devices from RaMedical acquisition.
- CEO Bob Moccia cites strong sales momentum and expects meaningful revenue impact in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123017913/0001140361-23-017913-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123017913/brhc20051325_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-017913

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer